Front. Oncol.
Frontiers in Oncology
Front. Oncol.
2234-943X
Frontiers Media S.A.
10.3389/fonc.2022.1106553
Oncology
Correction
Corrigendum: Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma
Van Hiep
Nguyen
1
2
3
Sun
Wei-Lun
4
5
6
Feng
Po-Hao
4
5
6
Lin
Cheng-Wei
1
6
7
Chen
Kuan-Yuan
4
5
6
8
Luo
Ching-Shan
1
4
6
Dung
Le Ngoc
3
Van Quyet
Hoang
3
Wu
Sheng-Ming
4
5
6
*
Lee
Kang-Yun
1
4
5
6
8
*
1
International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
2
Oncology Center, Bai Chay Hospital, Quang Ninh, Ha Long, Vietnam
3
Department of Thoracic and Neurological Surgery, Bai Chay Hospital, Quang Ninh, Ha Long, Vietnam
4
Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
5
Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
6
TMU Research Center for Thoracic Medicine, Taipei Medical University, Taipei, Taiwan
7
Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
8
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Kang-Yun Lee, leekangyun@tmu.edu.tw; Sheng-Ming Wu, chitosan@tmu.edu.tw
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
13
12
2022
2022
12
1106553
23
11
2022
29
11
2022
Copyright © 2022 Van Hiep, Sun, Feng, Lin, Chen, Luo, Dung, Van Quyet, Wu and Lee
2022
Van Hiep, Sun, Feng, Lin, Chen, Luo, Dung, Van Quyet, Wu and Lee
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A corrigendum on Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma. by Van Hiep N, Sun W-L, Feng P-H, Lin C-W, Chen K-Y, Luo C-S, Dung LN, Van Quyet H, Wu S-M and Lee K-Y (2022) Front. Oncol. 12:963896. doi: 10.3389/fonc.2022.963896
heparin-binding EGF-like growth factor (HBEGF)
bioinformatics
biomarker
immune infiltration
macrophage chemotaxis
non-small cell lung cancer
In the published article, there was an error in affiliation 1. Instead of “IInternational Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”, it should be “International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan”.
In the published article, there was an error in the Ethics statement. The IRB number was incorrectly displayed as “IRB no. N20210313”. The correct IRB number is “IRB no. N202103013”. The correct Ethics statement appears below.
Ethics statement
The study protocol was approved by the Joint Institutional Review Board of Taipei Medical University (IRB no. N202103013). The patients/participants provided their written informed consent to participate in this study.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.